Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	COL6A3 MEGF9 MUC17 MUC2 PRG4 MUC3A MUC5AC MUC6 IMPG2	3.91e-10	188	46	9	GO:0005201
GeneOntologyMolecularFunction	structural molecule activity	COL6A3 MEGF9 MUC17 POM121C MUC2 PRG4 MUC3A MUC5AC MUC6 IMPG2	2.81e-05	891	46	10	GO:0005198
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC17 MUC3A	3.11e-05	4	46	2	GO:0030197
GeneOntologyMolecularFunction	cargo receptor activity	HAVCR1 SSC5D PRG4	9.90e-04	85	46	3	GO:0038024
GeneOntologyCellularComponent	Golgi lumen	MUC3B MUC17 MUC19 MUC16 MUC5B MUC2 MUC3A MUC5AC MUC6	3.51e-12	109	49	9	GO:0005796
GeneOntologyCellularComponent	extracellular matrix	SSC5D COL6A3 MEGF9 MUC17 VASN MUC5B MUC2 PRG4 MUC5AC MUC6 IMPG2	2.63e-07	656	49	11	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	SSC5D COL6A3 MEGF9 MUC17 VASN MUC5B MUC2 PRG4 MUC5AC MUC6 IMPG2	2.71e-07	658	49	11	GO:0030312
GeneOntologyCellularComponent	mucus layer	MUC2 MUC5AC	1.61e-05	3	49	2	GO:0070701
GeneOntologyCellularComponent	collagen-containing extracellular matrix	SSC5D COL6A3 MEGF9 MUC17 MUC2 PRG4 IMPG2	2.21e-04	530	49	7	GO:0062023
Domain	TIL	MUC19 MUC5B MUC2 MUC5AC MUC6	7.07e-11	12	48	5	PF01826
Domain	C8	MUC19 MUC5B MUC2 MUC5AC MUC6	7.07e-11	12	48	5	PF08742
Domain	Unchr_dom_Cys-rich	MUC19 MUC5B MUC2 MUC5AC MUC6	1.15e-10	13	48	5	IPR014853
Domain	C8	MUC19 MUC5B MUC2 MUC5AC MUC6	1.15e-10	13	48	5	SM00832
Domain	SEA	MUC3B MUC17 MUC16 MUC3A IMPG2	1.78e-10	14	48	5	SM00200
Domain	TIL_dom	MUC19 MUC5B MUC2 MUC5AC MUC6	1.78e-10	14	48	5	IPR002919
Domain	VWD	MUC19 MUC5B MUC2 MUC5AC MUC6	3.87e-10	16	48	5	SM00216
Domain	VWF_type-D	MUC19 MUC5B MUC2 MUC5AC MUC6	3.87e-10	16	48	5	IPR001846
Domain	VWFD	MUC19 MUC5B MUC2 MUC5AC MUC6	3.87e-10	16	48	5	PS51233
Domain	VWD	MUC19 MUC5B MUC2 MUC5AC MUC6	3.87e-10	16	48	5	PF00094
Domain	VWC_out	MUC19 MUC5B MUC2 MUC5AC MUC6	1.02e-09	19	48	5	SM00215
Domain	CT	MUC19 MUC5B MUC2 MUC5AC MUC6	2.31e-09	22	48	5	SM00041
Domain	SEA	MUC3B MUC17 MUC16 MUC3A IMPG2	2.94e-09	23	48	5	PS50024
Domain	SEA_dom	MUC3B MUC17 MUC16 MUC3A IMPG2	2.94e-09	23	48	5	IPR000082
Domain	Cys_knot_C	MUC19 MUC5B MUC2 MUC5AC MUC6	4.63e-09	25	48	5	IPR006207
Domain	CTCK_2	MUC19 MUC5B MUC2 MUC5AC MUC6	4.63e-09	25	48	5	PS01225
Domain	VWF_dom	MUC19 MUC5B MUC2 MUC5AC MUC6	7.17e-08	42	48	5	IPR001007
Domain	CTCK_1	MUC19 MUC5B MUC2 MUC5AC	1.14e-07	18	48	4	PS01185
Domain	SEA	MUC3B MUC17 MUC16 IMPG2	2.71e-07	22	48	4	PF01390
Domain	WxxW_domain	MUC5B MUC2 MUC5AC	3.17e-07	6	48	3	IPR025155
Domain	Mucin2_WxxW	MUC5B MUC2 MUC5AC	3.17e-07	6	48	3	PF13330
Domain	VWC	MUC19 MUC5B MUC2 MUC5AC	2.66e-06	38	48	4	SM00214
Domain	VWFC_2	MUC19 MUC5B MUC2 MUC5AC	2.66e-06	38	48	4	PS50184
Domain	EGF-like_dom	HGFAC MUC3B MEGF9 MUC17 VASN MUC3A IMPG2	3.18e-06	249	48	7	IPR000742
Domain	EGF_1	HGFAC MUC3B MEGF9 MUC17 VASN MUC3A IMPG2	3.72e-06	255	48	7	PS00022
Domain	EGF-like_CS	HGFAC MUC3B MEGF9 MUC17 VASN MUC3A IMPG2	4.34e-06	261	48	7	IPR013032
Domain	EGF_2	HGFAC MUC3B MEGF9 MUC17 VASN MUC3A IMPG2	4.79e-06	265	48	7	PS01186
Domain	-	MUC17 MUC16 IMPG2	7.09e-06	15	48	3	3.30.70.960
Domain	EGF_3	HGFAC MUC3B MUC17 VASN MUC3A IMPG2	2.94e-05	235	48	6	PS50026
Domain	EGF	HGFAC MUC3B MEGF9 MUC17 VASN MUC3A	2.94e-05	235	48	6	SM00181
Domain	VWFC_1	MUC5B MUC2 MUC5AC	1.07e-04	36	48	3	PS01208
Domain	Glyco_hormone_CN	MUC5B MUC5AC	6.65e-04	15	48	2	IPR006208
Domain	Cys_knot	MUC5B MUC5AC	6.65e-04	15	48	2	PF00007
Domain	FN3	COL6A3 FNDC1 VASN NFASC	1.29e-03	185	48	4	SM00060
Domain	-	HAVCR1 COL6A3 FNDC1 TIMD4 VASN NFASC NFAT5	1.43e-03	663	48	7	2.60.40.10
Domain	FN3	COL6A3 FNDC1 VASN NFASC	1.69e-03	199	48	4	PS50853
Domain	FN3_dom	COL6A3 FNDC1 VASN NFASC	2.02e-03	209	48	4	IPR003961
Domain	Ig-like_fold	HAVCR1 COL6A3 FNDC1 TIMD4 VASN NFASC NFAT5	2.04e-03	706	48	7	IPR013783
Domain	VWC	MUC5B MUC5AC	2.34e-03	28	48	2	PF00093
Domain	KH_1	ANKRD17 ANKHD1	4.29e-03	38	48	2	PF00013
Domain	KH	ANKRD17 ANKHD1	4.74e-03	40	48	2	SM00322
Domain	KH_dom	ANKRD17 ANKHD1	4.74e-03	40	48	2	IPR004087
Domain	KH_TYPE_1	ANKRD17 ANKHD1	5.22e-03	42	48	2	PS50084
Domain	KH_dom_type_1	ANKRD17 ANKHD1	5.71e-03	44	48	2	IPR004088
Domain	fn3	FNDC1 VASN NFASC	8.33e-03	162	48	3	PF00041
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC17 MUC19 MUC16 MUC5B MUC2 MUC5AC MUC6	5.32e-14	21	37	7	MM15706
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC17 MUC16 MUC5B MUC3A MUC5AC MUC6	1.68e-12	16	37	6	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC17 MUC16 MUC5B MUC3A MUC5AC MUC6	2.59e-12	17	37	6	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC17 MUC16 MUC5B MUC3A MUC5AC MUC6	2.09e-11	23	37	6	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC17 MUC16 MUC5B MUC3A MUC5AC MUC6	4.73e-11	26	37	6	M27483
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC17 MUC19 MUC16 MUC5B MUC2 MUC5AC MUC6	1.64e-10	60	37	7	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC17 MUC19 MUC16 MUC5B MUC2 MUC5AC MUC6	1.16e-08	109	37	7	MM15164
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC17 MUC16 MUC5B MUC3A MUC5AC MUC6	1.18e-08	62	37	6	M546
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC17 MUC16 MUC5B MUC3A MUC5AC MUC6	2.08e-08	68	37	6	M27303
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC17 MUC16 MUC5B MUC3A MUC5AC MUC6	3.96e-07	111	37	6	M27416
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC17 MUC16 MUC5B MUC3A MUC5AC MUC6	1.55e-06	140	37	6	M27484
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC17 MUC16 MUC5B MUC3A MUC5AC MUC6	1.76e-06	143	37	6	M27275
Pathway	REACTOME_DISEASES_OF_METABOLISM	MUC17 MUC16 MUC5B MUC3A MUC5AC MUC6	4.29e-05	250	37	6	M27554
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	FOXK2 MUC17 LMO7 MUC19 MUC16 MUC5B MBD5 POM121C MUC2 MUC5AC MUC6	6.23e-04	1389	37	11	MM15307
Pathway	KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119	FOXK2 MBD5	2.09e-03	26	37	2	M47923
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC17 MUC19 MUC16 MUC5B MUC2 MUC3A MUC5AC MUC6	3.68e-19	18	49	8	18834073
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5B MUC2 MUC5AC MUC6	5.69e-18	6	49	6	19110483
Pubmed	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.	MUC5B MUC2 MUC5AC MUC6	3.48e-12	4	49	4	23807779
Pubmed	Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.	MUC5B MUC2 MUC5AC MUC6	3.48e-12	4	49	4	17471237
Pubmed	The mouse secreted gel-forming mucin gene cluster.	MUC5B MUC2 MUC5AC MUC6	3.48e-12	4	49	4	14984930
Pubmed	Characterization of mouse muc6 and evidence of conservation of the gel-forming mucin gene cluster between human and mouse.	MUC5B MUC2 MUC5AC MUC6	3.48e-12	4	49	4	12676567
Pubmed	Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells.	MUC5B MUC2 MUC5AC MUC6	3.48e-12	4	49	4	29869461
Pubmed	Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia.	MUC2 MUC5AC MUC6	2.63e-09	3	49	3	18300795
Pubmed	Expression of mucin 3 and mucin 5AC in arthritic synovial tissue.	MUC3B MUC3A MUC5AC	2.63e-09	3	49	3	18163520
Pubmed	Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.	MUC2 MUC5AC MUC6	2.63e-09	3	49	3	18825309
Pubmed	Mucin gene polymorphisms in otitis media patients.	MUC5B MUC2 MUC5AC	2.63e-09	3	49	3	19718741
Pubmed	Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin.	MUC3B MUC17 MUC3A	2.63e-09	3	49	3	10512748
Pubmed	Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritis.	MUC5B MUC2 MUC6	1.05e-08	4	49	3	21596555
Pubmed	Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas.	MUC2 MUC5AC MUC6	1.05e-08	4	49	3	33154304
Pubmed	Gastric mucin expression in first-degree relatives of gastric cancer patients.	MUC2 MUC5AC MUC6	1.05e-08	4	49	3	24901817
Pubmed	MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.	MUC2 MUC5AC MUC6	1.05e-08	4	49	3	27298226
Pubmed	Increased expression of MUC5AC and MUC5B promoting bacterial biofilm formation in chronic rhinosinusitis patients.	MUC5B MUC2 MUC5AC	1.05e-08	4	49	3	25638393
Pubmed	Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS).	MUC2 MUC5AC MUC6	1.05e-08	4	49	3	36367122
Pubmed	Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.	MUC5B MUC2 MUC5AC	1.05e-08	4	49	3	22269464
Pubmed	Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.	MUC2 MUC5AC MUC6	1.05e-08	4	49	3	17401217
Pubmed	Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.	MUC2 MUC5AC MUC6	1.05e-08	4	49	3	25298197
Pubmed	Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?	MUC2 MUC5AC MUC6	1.05e-08	4	49	3	20929551
Pubmed	Polymorphism of human mucin genes in chest disease: possible significance of MUC2.	MUC5B MUC2 MUC5AC	2.62e-08	5	49	3	11062147
Pubmed	Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?	MUC2 MUC5AC MUC6	2.62e-08	5	49	3	22261707
Pubmed	Differential expression of MUC genes in endometrial and cervical tissues and tumors.	MUC5B MUC2 MUC5AC	2.62e-08	5	49	3	16188033
Pubmed	Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies.	MUC5B MUC2 MUC6	2.62e-08	5	49	3	24840470
Pubmed	MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.	MUC2 MUC5AC MUC6	2.62e-08	5	49	3	16475027
Pubmed	Biosynthesis of gastrokine-2 in the human gastric mucosa: restricted spatial expression along the antral gland axis and differential interaction with TFF1, TFF2 and mucins.	MUC2 MUC5AC MUC6	5.24e-08	6	49	3	17982272
Pubmed	Human transcription factor protein interaction networks.	LHX2 FOXK2 ALMS1 VEZF1 PRCC ANKRD17 ELF2 YBX3 POGZ ANKHD1 POM121C CNOT1	4.97e-07	1429	49	12	35140242
Pubmed	Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5).	MUC5B MUC5AC	1.94e-06	2	49	2	7513696
Pubmed	Mucin deficiency causes functional and structural changes of the ocular surface.	MUC5B MUC5AC	1.94e-06	2	49	2	23272068
Pubmed	Intestinal MUC2 and gastric M1/MUC5AC in preneoplastic lesions induced by 1,2-dimethylhydrazine in rat: a sequential analysis.	MUC2 MUC5AC	1.94e-06	2	49	2	17203232
Pubmed	Muc5b is mainly expressed and sialylated in the nasal olfactory epithelium whereas Muc5ac is exclusively expressed and fucosylated in the nasal respiratory epithelium.	MUC5B MUC5AC	1.94e-06	2	49	2	31030254
Pubmed	Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B.	MUC5B MUC5AC	1.94e-06	2	49	2	27729120
Pubmed	Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma.	MUC2 MUC5AC	1.94e-06	2	49	2	20731025
Pubmed	MUC3 human intestinal mucin. Analysis of gene structure, the carboxyl terminus, and a novel upstream repetitive region.	MUC3B MUC3A	1.94e-06	2	49	2	9334251
Pubmed	Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.	MUC5B MUC5AC	1.94e-06	2	49	2	34058148
Pubmed	The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.	MUC5B MUC5AC	1.94e-06	2	49	2	37146737
Pubmed	The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium.	MUC5B MUC5AC	1.94e-06	2	49	2	23527003
Pubmed	MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.	MUC5B MUC5AC	1.94e-06	2	49	2	14988081
Pubmed	The complete genomic organization of the human MUC6 and MUC2 mucin genes.	MUC2 MUC6	1.94e-06	2	49	2	15081123
Pubmed	TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation.	HAVCR1 TIMD4	1.94e-06	2	49	2	15793576
Pubmed	Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion.	MUC5B MUC5AC	1.94e-06	2	49	2	16540890
Pubmed	TIM-1 rs41297579 G>A (-1454) and TIM-4 rs7700944 gene polymorphisms as possible risk factor for rheumatoid arthritis: relation to activity and severity.	HAVCR1 TIMD4	1.94e-06	2	49	2	25899833
Pubmed	Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.	MUC5B MUC5AC	1.94e-06	2	49	2	15563276
Pubmed	De novo NUF2 variant in a novel inherited bone marrow failure syndrome including microcephaly and renal hypoplasia.	MUC5B MUC5AC	1.94e-06	2	49	2	36111525
Pubmed	High-fat Diet Alters the Glycosylation Patterns of Duodenal Mucins in a Murine Model.	MUC2 MUC6	1.94e-06	2	49	2	32141795
Pubmed	Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis.	MUC16 MUC5AC	1.94e-06	2	49	2	18782111
Pubmed	MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis.	MUC2 MUC6	1.94e-06	2	49	2	20878553
Pubmed	Initiation of transcription of the MUC3A human intestinal mucin from a TATA-less promoter and comparison with the MUC3B amino terminus.	MUC3B MUC3A	1.94e-06	2	49	2	12958310
Pubmed	The expression of MUC5AC and MUC5B mucin genes in the mucosa of chronic rhinosinusitis and nasal polyposis.	MUC5B MUC5AC	1.94e-06	2	49	2	17621824
Pubmed	The role of T cell immunoglobulin mucin domains 1 and 4 in a herpes simplex virus-induced Behçet's disease mouse model.	HAVCR1 TIMD4	1.94e-06	2	49	2	24453431
Pubmed	Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.	MUC16 MUC5AC	1.94e-06	2	49	2	22220206
Pubmed	Muc5b is required for airway defence.	MUC5B MUC5AC	1.94e-06	2	49	2	24317696
Pubmed	Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma.	MUC5B MUC5AC	1.94e-06	2	49	2	27845589
Pubmed	Molecular cloning of cDNAs derived from a novel human intestinal mucin gene.	MUC3B MUC3A	1.94e-06	2	49	2	2393399
Pubmed	In vivo glycosylation of mucin tandem repeats.	MUC2 MUC5AC	1.94e-06	2	49	2	11445551
Pubmed	Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease.	MUC3B MUC3A	1.94e-06	2	49	2	11289722
Pubmed	TIM-4 expressed by mucosal dendritic cells plays a critical role in food antigen-specific Th2 differentiation and intestinal allergy.	HAVCR1 TIMD4	1.94e-06	2	49	2	17915221
Pubmed	Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells.	MUC5B MUC5AC	1.94e-06	2	49	2	22391959
Pubmed	C-Mannosylation of MUC5AC and MUC5B Cys subdomains.	MUC5B MUC5AC	1.94e-06	2	49	2	14718370
Pubmed	The expression of Tim-1 and Tim-4 molecules in regulatory T cells in type 1 diabetes.	HAVCR1 TIMD4	1.94e-06	2	49	2	31916216
Pubmed	Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules.	MUC5B MUC5AC	1.94e-06	2	49	2	35776514
Pubmed	Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells.	MUC2 MUC5AC	1.94e-06	2	49	2	12527922
Pubmed	Structures of T cell immunoglobulin mucin protein 4 show a metal-Ion-dependent ligand binding site where phosphatidylserine binds.	HAVCR1 TIMD4	1.94e-06	2	49	2	18083575
Pubmed	Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.	MUC5B MUC5AC	1.94e-06	2	49	2	27435107
Pubmed	Study of mucin turnover in the small intestine by in vivo labeling.	MUC17 MUC2	1.94e-06	2	49	2	29636525
Pubmed	The ocular surface phenotype of Muc5ac and Muc5b null mice.	MUC5B MUC5AC	1.94e-06	2	49	2	24327612
Pubmed	Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.	MUC5B MUC5AC	1.94e-06	2	49	2	26871672
Pubmed	Association between the TIMD4-HAVCR1 variants and serum lipid levels, coronary heart disease and ischemic stroke risk and atorvastatin lipid-lowering efficacy.	HAVCR1 TIMD4	1.94e-06	2	49	2	29208769
Pubmed	Studies of mucus in mouse stomach, small intestine, and colon. II. Gastrointestinal mucus proteome reveals Muc2 and Muc5ac accompanied by a set of core proteins.	MUC2 MUC5AC	1.94e-06	2	49	2	23832517
Pubmed	Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution.	MUC2 MUC5AC	1.94e-06	2	49	2	23832516
Pubmed	[Interleukin-1beta induces MUC2/MUC5B gene expression in human nasal epithelial cells].	MUC5B MUC2	1.94e-06	2	49	2	20873538
Pubmed	Mucin production during prenatal and postnatal murine lung development.	MUC5B MUC5AC	1.94e-06	2	49	2	21653907
Pubmed	Clinicopathological features of superficial non-ampurally duodenal epithelial tumor; gastric phenotype of histology correlates to higher malignant potency.	MUC5AC MUC6	1.94e-06	2	49	2	28321513
Pubmed	Human mucin genes MUC2, MUC3, MUC4, MUC5AC, MUC5B, and MUC6 express stable and extremely large mRNAs and exhibit a variable length polymorphism. An improved method to analyze large mRNAs.	MUC5AC MUC6	1.94e-06	2	49	2	9422745
Pubmed	TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells.	HAVCR1 TIMD4	1.94e-06	2	49	2	18082433
Pubmed	MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium.	MUC5B MUC5AC	1.94e-06	2	49	2	36427316
Pubmed	Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution.	MUC5AC MUC6	1.94e-06	2	49	2	11988092
Pubmed	The TIM-1:TIM-4 pathway enhances renal ischemia-reperfusion injury.	HAVCR1 TIMD4	1.94e-06	2	49	2	21355054
Pubmed	Temporal analysis of goblet cells and mucin gene expression in murine models of allergic asthma.	MUC2 MUC5AC	1.94e-06	2	49	2	14594655
Pubmed	Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin.	MUC5B MUC5AC	1.94e-06	2	49	2	32348677
Pubmed	In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model.	MUC5B MUC5AC	1.94e-06	2	49	2	11587997
Pubmed	Gel-forming mucins form distinct morphologic structures in airways.	MUC5B MUC5AC	1.94e-06	2	49	2	28607090
Pubmed	A new development of FG-CC' siRNA blocking interaction of Tim-1 and Tim-4 can enhance DC vaccine against gastric cancer .	HAVCR1 TIMD4	1.94e-06	2	49	2	22709877
Pubmed	Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B.	MUC3B MUC3A	1.94e-06	2	49	2	10973822
Pubmed	The central exons of the human MUC2 and MUC6 mucins are highly repetitive and variable in sequence between individuals.	MUC2 MUC6	1.94e-06	2	49	2	30504806
Pubmed	Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.	MUC5AC MUC6	1.94e-06	2	49	2	12360467
Pubmed	Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.	MUC16 MUC5AC	1.94e-06	2	49	2	24722639
Pubmed	Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis.	MUC5B MUC5AC	1.94e-06	2	49	2	24332705
Pubmed	Abnormal subcellular distribution of mature MUC2 and de novo MUC5AC mucins in adenomas of the rectum: immunohistochemical detection using non-VNTR antibodies to MUC2 and MUC5AC peptide.	MUC2 MUC5AC	1.94e-06	2	49	2	12820724
Pubmed	The MUC3 gene encodes a transmembrane mucin and is alternatively spliced.	MUC3B MUC3A	1.94e-06	2	49	2	10405327
Pubmed	Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma.	MUC5B MUC5AC	1.94e-06	2	49	2	34656442
Pubmed	Mucolytic activity of bacterial and human chitinases.	MUC2 MUC5AC	1.94e-06	2	49	2	17321686
Pubmed	Two atypical enteropathogenic Escherichia coli strains induce the production of secreted and membrane-bound mucins to benefit their own growth at the apical surface of human mucin-secreting intestinal HT29-MTX cells.	MUC17 MUC2	5.83e-06	3	49	2	20065027
Pubmed	Evidence for carbohydrate recognition and homotypic and heterotypic binding by the TIM family.	HAVCR1 TIMD4	5.83e-06	3	49	2	17513880
Pubmed	Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren's syndrome-associated dry eyes.	MUC16 MUC5AC	5.83e-06	3	49	2	33232357
Pubmed	Interleukin-33 induces mucin gene expression and goblet cell hyperplasia in human nasal epithelial cells.	MUC5B MUC5AC	5.83e-06	3	49	2	27776277
Pubmed	Significant association between TIM1 promoter polymorphisms and protection against cerebral malaria in Thailand.	HAVCR1 TIMD4	5.83e-06	3	49	2	18294362
Pubmed	Genetic variation in MUC1, MUC2 and MUC6 genes and evolution of gastric cancer precursor lesions in a long-term follow-up in a high-risk area in Spain.	MUC2 MUC6	5.83e-06	3	49	2	22402132
Interaction	FHL2 interactions	ATXN2L FOXK2 ALMS1 ANKRD17 SLAIN1 POGZ WNK1 NFAT5 CNOT1	2.31e-07	396	46	9	int:FHL2
Cytoband	11p15.5	MUC5B MUC2 MUC5AC MUC6	8.03e-06	118	49	4	11p15.5
Cytoband	7q22	MUC3B MUC3A	7.65e-04	38	49	2	7q22
Cytoband	4q13.3	OPRPN ANKRD17	9.35e-04	42	49	2	4q13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr13q22	LMO7 SLAIN1	2.03e-03	62	49	2	chr13q22
Cytoband	Ensembl 112 genes in cytogenetic band chr11p15	MUC5B MUC2 MUC5AC MUC6	3.08e-03	564	49	4	chr11p15
Cytoband	Ensembl 112 genes in cytogenetic band chr12p13	MANSC1 YBX3 WNK1	6.39e-03	353	49	3	chr12p13
Cytoband	Ensembl 112 genes in cytogenetic band chr5q33	HAVCR1 TIMD4	7.12e-03	118	49	2	chr5q33
Cytoband	Ensembl 112 genes in cytogenetic band chr9q33	LHX2 MEGF9	9.62e-03	138	49	2	chr9q33
GeneFamily	CD molecules\|Mucins	MUC3B MUC17 MUC19 MUC16 MUC5B MUC22 MUC2 MUC3A MUC5AC MUC6	4.45e-23	21	34	10	648
Coexpression	NABA_ECM_AFFILIATED	OPRPN MUC17 MUC19 MUC16 MUC5B MUC22 MUC2 MUC3A MUC5AC MUC6	5.33e-13	170	48	10	M5880
Coexpression	NABA_MATRISOME	OPRPN HGFAC COL6A3 FNDC1 MEGF9 MUC17 MUC19 MUC16 MUC5B MUC22 MUC2 PRG4 MUC3A MUC5AC MUC6 IMPG2	1.88e-11	1026	48	16	M5889
Coexpression	NABA_MATRISOME_ASSOCIATED	OPRPN HGFAC MEGF9 MUC17 MUC19 MUC16 MUC5B MUC22 MUC2 MUC3A MUC5AC MUC6	7.59e-09	751	48	12	M5885
Coexpression	NABA_ECM_AFFILIATED	MUC17 MUC19 MUC16 MUC5B MUC2 MUC5AC MUC6	1.51e-08	158	48	7	MM17063
Coexpression	NABA_MATRISOME	HGFAC COL6A3 FNDC1 MEGF9 MUC17 MUC19 MUC16 MUC5B MUC2 PRG4 MUC5AC MUC6 IMPG2	2.06e-08	1008	48	13	MM17056
Coexpression	NABA_MATRISOME_ASSOCIATED	HGFAC MEGF9 MUC17 MUC19 MUC16 MUC5B MUC2 MUC5AC MUC6	6.65e-06	738	48	9	MM17058
Coexpression	GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	ALMS1 MEGF9 LMO7 MBD5	7.19e-05	121	48	4	M9157
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#4_top-relative-expression-ranked_1000	ANKRD17 HUWE1 KDM6B NFAT5	2.48e-05	75	48	4	gudmap_developingGonad_e14.5_ ovary_1000_k4
ToppCell	nucseq-Epithelial-Epithelial_Glandular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC17 SYTL5 MUC16 MUC5B MUC3A MUC5AC MGAM2	9.00e-10	179	48	7	859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC17 SYTL5 MUC16 MUC5B MUC3A MUC5AC MGAM2	9.35e-10	180	48	7	3dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC17 SYTL5 MUC16 MUC5B MUC3A MUC5AC MGAM2	9.35e-10	180	48	7	668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCell	Control-Epithelial_cells-Airway_goblet\|Control / group, cell type (main and fine annotations)	MUC17 SYTL5 MUC16 MUC5B MUC3A MUC5AC MGAM2	1.09e-09	184	48	7	d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	MUC17 MUC16 MUC5B MUC3A MUC5AC MGAM2	4.44e-08	183	48	6	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D COL6A3 FNDC1 VASN YBX3 PRG4	6.67e-08	196	48	6	fcb275746bf51269ed8ba4cf93edb054a45f1ccd
ToppCell	facs-Heart-RV-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 FNDC1 ALMS1 PRCC VASN	1.09e-06	170	48	5	d7c9a604311974ff87ece43a0f8725a234d262f7
ToppCell	droplet-Limb_Muscle\|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 FNDC1 VASN KDM6B PRG4	1.88e-06	190	48	5	06c2b13fa88abbcb8086f13b8d98a156e41e4198
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MANSC1 MUC16 MUC5B YBX3 MUC5AC	1.98e-06	192	48	5	612be3f861bd2f71a31c57f48c8b10930c3471ea
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MANSC1 MUC16 MUC5B YBX3 MUC5AC	1.98e-06	192	48	5	f627a3f43e2340c8ba502211940171f25c7ff436
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC3A MUC5AC MUC6 ADGRG4 MGAM2	2.14e-06	195	48	5	23ab7e2a419377c05bab0e92a2457afbcd3d9e07
ToppCell	BL-critical-LOC-Epithelial-Secretory_LYPD2\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LMO7 MUC16 MUC5B MUC2 MUC5AC	2.30e-06	198	48	5	484d16aaa601a1e11b871b0475dd01a2de1a29ce
ToppCell	background-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	LHX2 SSC5D COL6A3 FNDC1 NFASC	2.30e-06	198	48	5	79f32f965aed6a10c5cb803173e3db7b32e07a91
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_secretory\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LMO7 SYTL5 MUC16 MUC5B MUC5AC	2.36e-06	199	48	5	7223f853335492ca617dbec3e4b6872a8a463a45
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LMO7 SYTL5 MUC16 MUC5B MUC5AC	2.36e-06	199	48	5	e03bdc7cb825e287f41b834ec6061d23c1c03b04
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D COL6A3 FNDC1 VASN PRG4	2.36e-06	199	48	5	edd5300da1a3b758210ff8f949e9d1988b8bc7e2
ToppCell	Parenchyma_COVID-19-Epithelial-TX-Club\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	LMO7 SYTL5 MUC16 MUC5B MUC5AC	2.42e-06	200	48	5	85f946dd3831acf3488c87efba96689cc2667c3a
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Club-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LMO7 SYTL5 MUC16 MUC5B MUC5AC	2.42e-06	200	48	5	8a44a4f7ea9358f2194a490e79601c98ff7fdcb0
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Club\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	LMO7 SYTL5 MUC16 MUC5B MUC5AC	2.42e-06	200	48	5	30d428510c68da96c7c8cfd472f449ebb9631132
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-5\|TCGA-Colorectal / Sample_Type by Project: Shred V9	SYTL5 SLAIN1 MUC2 MUC5AC	2.46e-05	157	48	4	5fb41af247465aa29aa7b8edd26e3d3794766f80
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LMO7 MUC16 MUC5B MUC5AC	2.59e-05	159	48	4	60b1f4dce2ce0911160fda17f137c064da31e2eb
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D COL6A3 PRG4 MUC5AC	2.99e-05	165	48	4	f80665b75d43f1bf6919d59fc762e7e0bac653f2
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SSC5D PRCC VASN PRG4	3.14e-05	167	48	4	f4943fb5001475ddab82a0273bcbb3fa68fdd7bd
ToppCell	BAL-Severe-cDC_5\|Severe / Compartment, Disease Groups and Clusters	HAVCR1 LHX2 NFASC KDM6B	3.21e-05	168	48	4	857a80c217a5513553460798a625612031bc7bb7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SSC5D COL6A3 NFASC PRG4	3.21e-05	168	48	4	d19a115365c5415e51c039718d7669de788fcf33
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	SYTL5 MUC5B MUC5AC MUC6	3.52e-05	172	48	4	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 FNDC1 ALMS1 PRCC	3.85e-05	176	48	4	c0a084f7a8645262d61971f094689e02bf15b113
ToppCell	facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 FNDC1 ALMS1 PRCC	3.85e-05	176	48	4	cccf9201f6e2da7524b911a5961d3b227edab222
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Paneth\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYTL5 SLAIN1 MUC5B MUC5AC	3.94e-05	177	48	4	2af09028014f4ec3b7d2a4c286f1ae5e84a9f590
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LMO7 MUC16 MUC5B MUC5AC	4.02e-05	178	48	4	9a3ef66814dfca7b37024e7f79e86ea8c72ae10f
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	LMO7 MUC16 MUC5B MUC5AC	4.02e-05	178	48	4	19b5432aa1d7f616d58a106543c18cf2d7ca840c
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LMO7 MUC16 MUC5B MUC5AC	4.02e-05	178	48	4	b413a634283550fa224db7d0d05956e3f64694a1
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LMO7 MUC16 MUC5B MUC5AC	4.02e-05	178	48	4	49a2271718637522f74334068d252963ee13b1ce
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LMO7 MUC16 MUC5B MUC5AC	4.11e-05	179	48	4	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 FNDC1 VASN KDM6B	4.20e-05	180	48	4	12537d8a569faa69f474284d2c201475722b8ca1
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HAVCR1 SYTL5 MUC3A ADGRG4	4.20e-05	180	48	4	8ba9bba0c9fecf184a4332ba4585fb2439f68cd3
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SSC5D COL6A3 LMO7 NFASC	4.29e-05	181	48	4	a2058d658f07ab6f0a28d2622f3090b4cde6f763
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SSC5D COL6A3 LMO7 NFASC	4.29e-05	181	48	4	526e858a848470b6d2d5248788004d9735ed3add
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SSC5D COL6A3 FNDC1 VASN	4.29e-05	181	48	4	eea943fdcbef0bbaa8578f3296923e874893b405
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SSC5D COL6A3 FNDC1 VASN	4.29e-05	181	48	4	9c157de9d3403e092c907599f2a2c16db5b21131
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HAVCR1 SYTL5 MUC3A ADGRG4	4.39e-05	182	48	4	e98ca9df33a1a81fc83ecf73d5141a14f2bc985c
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC5B MUC5AC MUC6 ADGRG4	4.48e-05	183	48	4	263937906ddabc798bbe60f0da28ba859a5c72e2
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SSC5D COL6A3 FNDC1 VASN	4.48e-05	183	48	4	bc7dd6a40ec9c773d005c1a46f305d40cdd0a326
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B MUC5AC MUC6	4.58e-05	184	48	4	01c19a830348ab0b9c02c1546a439de70ee10f97
ToppCell	Severe_COVID-19-Epithelial-undefined_Epi\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	LMO7 MUC16 MUC5B MUC5AC	5.08e-05	189	48	4	8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	LMO7 ANKRD17 MBD5 NFAT5	5.08e-05	189	48	4	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SSC5D COL6A3 VASN ADGRG4	5.08e-05	189	48	4	d531399749409d614adca13d181830c6e3287508
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	LMO7 MUC16 MUC5B MUC5AC	5.18e-05	190	48	4	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B MUC5AC MUC6	5.18e-05	190	48	4	3c337374d89e69cc0a78e65a4a7e21db7b050fcd
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B MUC5AC MUC6	5.18e-05	190	48	4	23f2ac4da431211084bb6ab0494c2e0b69547cb6
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SSC5D COL6A3 FNDC1 VASN	5.29e-05	191	48	4	0fae1c2ef9f83ac7721d0a9d69455bf97eed9257
ToppCell	ASK454-Mesenchymal-Fibroblast\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	SSC5D COL6A3 NFASC PRG4	5.29e-05	191	48	4	1726add3f392a061536b7aff72ba84303f4a0b1f
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D COL6A3 FNDC1 VASN	5.29e-05	191	48	4	1b26056df078674f37a6c06f6256b30cfcec21a7
ToppCell	ASK454-Mesenchymal\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	SSC5D COL6A3 NFASC PRG4	5.29e-05	191	48	4	e30ae7a12439f8a79820b13f03e822c1223fd0cb
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D FNDC1 VASN PRG4	5.40e-05	192	48	4	b35f0e422070ba9c7c1d9ff3eace4edc10286cde
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D COL6A3 FNDC1 VASN	5.40e-05	192	48	4	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	droplet-Fat-Scat-18m-Mesenchymal-Cd34+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D COL6A3 VASN PRG4	5.51e-05	193	48	4	316ebdf15f75d88c348f909b643fcd315364ca84
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D COL6A3 FNDC1 VASN	5.51e-05	193	48	4	eff718664fe0aaf89050efd9cc7b6dfb1df46666
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SSC5D COL6A3 FNDC1 NFASC	5.51e-05	193	48	4	dc8e62df6121ee99b156aca6b1b3ae555739b6f2
ToppCell	droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D COL6A3 VASN PRG4	5.51e-05	193	48	4	1afdd3f7d703f4204a2cbfe40e135ac7b09213f7
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D COL6A3 FNDC1 PRG4	5.51e-05	193	48	4	49600db68ed65cafc67bd45a285b364e4f5f88af
ToppCell	droplet-Fat-Scat-18m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D COL6A3 VASN PRG4	5.51e-05	193	48	4	8dc6db335678f3a5cfd36026ad811fed8d9cb4bc
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D COL6A3 FNDC1 VASN	5.51e-05	193	48	4	428b1a3ad87dff7f65de5161d40f102572a9341b
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D COL6A3 FNDC1 PRG4	5.51e-05	193	48	4	45b5cab4dfeb0ed3b13631db5963740a792b810f
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SSC5D COL6A3 FNDC1 NFASC	5.51e-05	193	48	4	e2ee077fd381bd906e6b4329f22e7d106e422a7f
ToppCell	5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC17 MUC2 MUC3A MGAM2	5.62e-05	194	48	4	2f6e62a4ec8707bd5a16c0734c5131af55207ea2
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SSC5D COL6A3 FNDC1 VASN	5.62e-05	194	48	4	8fae8061b350336299aa81f378e07deadbd55123
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SSC5D COL6A3 FNDC1 VASN	5.62e-05	194	48	4	4d7d24390fdb379f943ddcc70a63f23955e10163
ToppCell	NS-critical-LOC-Epithelial-Secretory\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SYTL5 MUC16 MUC5B MUC5AC	5.73e-05	195	48	4	b0d782eeee30c797b4da9b3be29b864983fd9e71
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MANSC1 MUC16 MUC5B MUC5AC	5.73e-05	195	48	4	2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LMO7 MUC16 MUC5B MUC5AC	5.85e-05	196	48	4	c18874f37b90e6afacc562b2082b67ea8a7cb4a4
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LMO7 MUC16 MUC5B MUC5AC	5.85e-05	196	48	4	91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LMO7 MUC16 MUC5B MUC5AC	5.85e-05	196	48	4	e819088a74d29e958371aa851ac9c74ec55367b7
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	LMO7 MUC16 MUC5B MUC5AC	5.85e-05	196	48	4	e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LMO7 MUC16 MUC5B MUC5AC	5.85e-05	196	48	4	7a4d502550e9e37dc42f2ff1be3c896afe365d7f
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LMO7 MUC16 MUC5B MUC5AC	5.85e-05	196	48	4	a52879a4c822c5e4be569f01f845a795e00c5f4b
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LMO7 MUC16 MUC5B MUC5AC	5.85e-05	196	48	4	60ea673ed887fe3890c5cf4ff4165384b76d7361
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LMO7 MUC16 MUC5B MUC5AC	5.85e-05	196	48	4	a4d05d85fbafa869df19bba3881020ea433d81fb
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SSC5D COL6A3 FNDC1 VASN	5.97e-05	197	48	4	16758f181ef07c60aee63072e1da9572c5c85414
ToppCell	distal-Epithelial-Goblet\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MUC16 MUC5B MUC2 MUC5AC	5.97e-05	197	48	4	da1ed7303cc9cb2d205c0e5c49c52544d3540951
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SSC5D COL6A3 FNDC1 NFASC	5.97e-05	197	48	4	4cf4e9553397cd8dee883dbec24f41bec41aff99
ToppCell	Bronchus_Control_(B.)\|World / Sample group, Lineage and Cell type	MUC16 MUC5B KDM6B MUC5AC	5.97e-05	197	48	4	b6dff2ee108813e18657e2d8cf850e2423f8c8e9
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SSC5D COL6A3 VASN ADGRG4	5.97e-05	197	48	4	c747c496ac090309b7f8a3e9d840928f12c83f2f
ToppCell	(2)_Fibroblasts-(24)_Fibro-5\|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis	SSC5D COL6A3 FNDC1 WNK1	5.97e-05	197	48	4	83a4b79fbfa1cf63441dee4424c3b87c988287bf
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SSC5D COL6A3 VASN PRG4	5.97e-05	197	48	4	71786e9432e2d649f5d86f639abb25e7102deb67
ToppCell	distal-3-Epithelial-Goblet\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MUC16 MUC5B MUC2 MUC5AC	5.97e-05	197	48	4	a00784ccfb1de6a96b91e2a8a2889b69f31a33da
ToppCell	Mild_COVID-19-Epithelial-Basal/Club\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	LMO7 MUC16 MUC5B MUC5AC	5.97e-05	197	48	4	4cc5b778e1e2c6c149160fa147c172977c0fa8eb
ToppCell	distal-Epithelial-Goblet-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MUC16 MUC5B MUC2 MUC5AC	5.97e-05	197	48	4	3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A3 VASN NFASC PRG4	5.97e-05	197	48	4	3fe665c0277d091290b63f0dd24c0c6536a45309
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SSC5D COL6A3 FNDC1 LMO7	6.08e-05	198	48	4	c55608633f66e3d434c5d81324efb07c5120d2c2
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SSC5D COL6A3 FNDC1 LMO7	6.08e-05	198	48	4	3e5459038fc6ed95f529eb4d1dc5113e16c19012
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	SSC5D COL6A3 FNDC1 LMO7	6.08e-05	198	48	4	196257c4420ac801ed9fbb444f11718adb7560ae
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D COL6A3 FNDC1 VASN	6.08e-05	198	48	4	1b90d632e59c3c47b936e829cceeb0334f05f34f
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 FNDC1 LMO7 VASN	6.08e-05	198	48	4	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D COL6A3 FNDC1 VASN	6.08e-05	198	48	4	524305c5d7b1d53e86ec0af775efefa3e0955e47
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	LHX2 SSC5D COL6A3 NFASC	6.08e-05	198	48	4	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 FNDC1 LMO7 VASN	6.08e-05	198	48	4	9d61483b0decac2fe90045b3474843360b2c49b3
ToppCell	distal-1-mesenchymal-Mesothelial\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SSC5D FNDC1 MUC16 PRG4	6.20e-05	199	48	4	8dd5b411d2f1626830b77a1616cc3fb67dc59338
ToppCell	droplet-Trachea\|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 VASN KDM6B PRG4	6.20e-05	199	48	4	1c7d30765ddb2291967da5d15664c6238c680c1d
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Club\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	LMO7 SYTL5 MUC5B MUC5AC	6.20e-05	199	48	4	111cfd589ec6795075d8d88d7664bfb23eba5bf6
Drug	mucic acid	HAVCR1 MUC3B TIMD4 MUC3A MUC5AC	1.04e-06	88	47	5	CID000000607
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MUC2 MUC3A MUC5AC MUC6	1.06e-09	64	49	6	DOID:4947 (is_marker_for)
Disease	mucinous adenocarcinoma (is_marker_for)	MUC2 MUC5AC MUC6	4.29e-08	5	49	3	DOID:3030 (is_marker_for)
Disease	cystitis (is_marker_for)	MUC2 MUC5AC	2.70e-06	2	49	2	DOID:1679 (is_marker_for)
Disease	keratoconjunctivitis (is_marker_for)	MUC16 MUC5AC	8.10e-06	3	49	2	DOID:9368 (is_marker_for)
Disease	sputum mucin-5B amount	MUC2 MUC5AC	8.10e-06	3	49	2	OBA_2050332
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16 MUC5AC	8.50e-06	24	49	3	DOID:12894 (is_marker_for)
Disease	cholesteryl esters to total lipids in large LDL percentage	HAVCR1 HGFAC TIMD4	1.87e-05	31	49	3	EFO_0022249
Disease	hepatitis A virus cellular receptor 1 measurement	HAVCR1 TIMD4	2.69e-05	5	49	2	EFO_0010601
Disease	smoking status measurement, inflammatory bowel disease	MUC22 WDFY4	5.64e-05	7	49	2	EFO_0003767, EFO_0006527
Disease	phospholipids in medium LDL measurement	HAVCR1 HGFAC TIMD4	7.51e-05	49	49	3	EFO_0022183
Disease	cholesterol in medium LDL measurement	HAVCR1 HGFAC TIMD4	7.51e-05	49	49	3	EFO_0022224
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	HAVCR1 HGFAC TIMD4 ANKRD17	8.01e-05	137	49	4	EFO_0004611, EFO_0008591
Disease	phospholipids in medium VLDL measurement	HAVCR1 HGFAC TIMD4	8.98e-05	52	49	3	EFO_0022154
Disease	total lipids in medium LDL	HAVCR1 HGFAC TIMD4	8.98e-05	52	49	3	EFO_0022180
Disease	bringing up phlegm, sputum or mucus on most days, self-reported	MUC2 MUC5AC	9.65e-05	9	49	2	EFO_0009824
Disease	hyperlipidemia	HAVCR1 TIMD4	9.65e-05	9	49	2	MONDO_0021187
Disease	total lipids in medium VLDL	HAVCR1 HGFAC TIMD4	1.01e-04	54	49	3	EFO_0022153
Disease	triglycerides in medium VLDL measurement	HAVCR1 HGFAC TIMD4	1.06e-04	55	49	3	EFO_0022155
Disease	triglycerides in LDL measurement	HAVCR1 HGFAC TIMD4	1.12e-04	56	49	3	EFO_0022320
Disease	triglycerides in very large VLDL measurement	HAVCR1 HGFAC TIMD4	1.12e-04	56	49	3	EFO_0022325
Disease	triglycerides in large VLDL measurement	HAVCR1 HGFAC TIMD4	1.12e-04	56	49	3	EFO_0022178
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC5AC	1.21e-04	10	49	2	DOID:10140 (is_marker_for)
Disease	triglycerides in VLDL measurement	HAVCR1 HGFAC TIMD4	1.31e-04	59	49	3	EFO_0022326
Disease	phospholipids in VLDL measurement	HAVCR1 HGFAC TIMD4	1.31e-04	59	49	3	EFO_0022301
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	HAVCR1 HGFAC TIMD4	1.31e-04	59	49	3	EFO_0022260
Disease	phospholipids in small VLDL measurement	HAVCR1 HGFAC TIMD4	1.38e-04	60	49	3	EFO_0022146
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	HAVCR1 HGFAC TIMD4	1.38e-04	60	49	3	EFO_0021898
Disease	total lipids in VLDL measurement	HAVCR1 HGFAC TIMD4	1.38e-04	60	49	3	EFO_0022314
Disease	triglycerides in small VLDL measurement	HAVCR1 HGFAC TIMD4	1.45e-04	61	49	3	EFO_0022145
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B MUC3A MUC5AC	1.45e-04	61	49	3	DOID:3587 (is_marker_for)
Disease	free cholesterol in very large VLDL measurement	HAVCR1 HGFAC TIMD4	1.45e-04	61	49	3	EFO_0022274
Disease	free cholesterol in VLDL measurement	HAVCR1 HGFAC TIMD4	1.45e-04	61	49	3	EFO_0022276
Disease	pulmonary fibrosis	MUC5B MUC5AC	1.47e-04	11	49	2	EFO_0009448
Disease	triglycerides in medium LDL measurement	HAVCR1 HGFAC TIMD4	1.52e-04	62	49	3	EFO_0022322
Disease	phospholipids in large VLDL measurement	HAVCR1 HGFAC TIMD4	1.52e-04	62	49	3	EFO_0022169
Disease	total lipids in chylomicrons and extremely large VLDL measurement	HAVCR1 HGFAC TIMD4	1.52e-04	62	49	3	EFO_0022306
Disease	total lipids in very large VLDL measurement	HAVCR1 HGFAC TIMD4	1.52e-04	62	49	3	EFO_0022313
Disease	free cholesterol in chylomicrons and extremely large VLDL measurement	HAVCR1 HGFAC TIMD4	1.52e-04	62	49	3	EFO_0022263
Disease	cystic fibrosis (is_marker_for)	MUC5B MUC2 MUC5AC	1.52e-04	62	49	3	DOID:1485 (is_marker_for)
Disease	phospholipids in very large VLDL measurement	HAVCR1 HGFAC TIMD4	1.52e-04	62	49	3	EFO_0022299
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	HAVCR1 HGFAC TIMD4	1.59e-04	63	49	3	EFO_0022292
Disease	triglycerides in small LDL measurement	HAVCR1 HGFAC TIMD4	1.75e-04	65	49	3	EFO_0022323
Disease	cholesterol in large VLDL measurement	HAVCR1 HGFAC TIMD4	1.75e-04	65	49	3	EFO_0021902
Disease	cholesterol in very large VLDL measurement	HAVCR1 HGFAC TIMD4	1.75e-04	65	49	3	EFO_0022230
Disease	total lipids in small VLDL	HAVCR1 HGFAC TIMD4	1.91e-04	67	49	3	EFO_0022148
Disease	total lipids in large VLDL	HAVCR1 HGFAC TIMD4	1.91e-04	67	49	3	EFO_0022175
Disease	triglycerides in very small VLDL measurement	HAVCR1 HGFAC TIMD4	2.00e-04	68	49	3	EFO_0022144
Disease	free cholesterol in large VLDL measurement	HAVCR1 HGFAC TIMD4	2.00e-04	68	49	3	EFO_0022265
Disease	gastric ulcer (implicated_via_orthology)	MUC5AC MUC6	2.43e-04	14	49	2	DOID:10808 (implicated_via_orthology)
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	HAVCR1 HGFAC TIMD4	3.00e-04	78	49	3	EFO_0022187
Disease	amyloid-beta measurement, Alzheimer's disease biomarker measurement	HAVCR1 TIMD4	3.19e-04	16	49	2	EFO_0005194, EFO_0006514
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	HAVCR1 HGFAC TIMD4 NFAT5	3.42e-04	200	49	4	EFO_0004611, EFO_0020945
Disease	pulse pressure measurement	HGFAC COL6A3 FNDC1 VASN POGZ KDM6B MBD5 NFAT5 CNOT1	4.20e-04	1392	49	9	EFO_0005763
Disease	lipid measurement, lipoprotein measurement	HAVCR1 HGFAC TIMD4	4.57e-04	90	49	3	EFO_0004529, EFO_0004732
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement	HAVCR1 HGFAC TIMD4	5.35e-04	95	49	3	EFO_0004529, EFO_0008317, EFO_0008596
Disease	Inhalant adrenergic use measurement	MUC16 MUC2 MUC5AC	5.52e-04	96	49	3	EFO_0009941
Disease	chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement	HAVCR1 HGFAC TIMD4	5.52e-04	96	49	3	EFO_0004530, EFO_0008317, EFO_0008596
Disease	pancreatic cancer (is_marker_for)	MUC16 MUC5AC MUC6	6.40e-04	101	49	3	DOID:1793 (is_marker_for)
Disease	familial hyperlipidemia	HAVCR1 HGFAC TIMD4	7.36e-04	106	49	3	MONDO_0001336
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	HAVCR1 HGFAC TIMD4	7.36e-04	106	49	3	EFO_0008317, EFO_0008596
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement	HAVCR1 HGFAC TIMD4	7.98e-04	109	49	3	EFO_0004639, EFO_0008317, EFO_0008596
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	HAVCR1 HGFAC TIMD4	8.20e-04	110	49	3	EFO_0008317, EFO_0008596, EFO_0010351
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	HAVCR1 HGFAC TIMD4	8.20e-04	110	49	3	EFO_0008317, EFO_0008591, EFO_0008596
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	HAVCR1 HGFAC TIMD4	8.20e-04	110	49	3	EFO_0004574, EFO_0008317, EFO_0008596
Disease	low density lipoprotein cholesterol measurement, lipid measurement	HAVCR1 HGFAC TIMD4	9.09e-04	114	49	3	EFO_0004529, EFO_0004611
Disease	total cholesterol measurement, low density lipoprotein cholesterol measurement	HAVCR1 HGFAC TIMD4	9.09e-04	114	49	3	EFO_0004574, EFO_0004611
Disease	antihyperlipidemic drug use measurement	HAVCR1 HGFAC TIMD4	9.32e-04	115	49	3	EFO_0803367
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	HAVCR1 HGFAC TIMD4	1.05e-03	120	49	3	EFO_0004611, EFO_0004639
Disease	cholesteryl ester measurement, low density lipoprotein cholesterol measurement	HAVCR1 HGFAC TIMD4	1.21e-03	126	49	3	EFO_0004611, EFO_0010351
Disease	asthma (is_marker_for)	HAVCR1 MUC5B MUC5AC	1.21e-03	126	49	3	DOID:2841 (is_marker_for)
Disease	esterified cholesterol measurement	HAVCR1 TIMD4 ANKRD17	1.27e-03	128	49	3	EFO_0008589
Disease	response to aromatase inhibitor	MUC16 CNOT1	1.30e-03	32	49	2	GO_0061477
Disease	polyunsaturated fatty acid measurement	HAVCR1 HGFAC TIMD4	1.36e-03	131	49	3	EFO_0010733
Disease	very low density lipoprotein particle size measurement	HAVCR1 HGFAC TIMD4	1.42e-03	133	49	3	EFO_0008594
Disease	COVID-19 symptoms measurement	MUC5B MUC5AC	1.55e-03	35	49	2	EFO_0600019

Protein segments in the cluster

Peptide	Gene	Start	Entry
VISTTSTPEATQPIS	ADGRG4	1161	Q8IZF6
PVDQTTGTPTVTSTS	ALMS1	1366	Q8TCU4
TEPPSATTTTTIGIS	ANKRD17	1531	O75179
VPTSSASIPVTSSVS	ATXN2L	471	Q8WWM7
PPTTELETATTTTTQ	MUC5B	1611	Q9HC84
TTPTTRGSTVTPSSI	MUC5B	2081	Q9HC84
TEPSTTATVTVPTGS	MUC5B	2466	Q9HC84
EPSTTATVTVPTGST	MUC5B	3166	Q9HC84
SSPTSAPITTVVTTG	MUC5B	3556	Q9HC84
ILTEPSTTATVTVPT	MUC5B	3721	Q9HC84
GTTHTPTVLTTTTTT	MUC5B	3911	Q9HC84
TEPSTTATVTVPTGS	MUC5B	4451	Q9HC84
STSVAAPITTSVPSV	MUC16	551	Q8WXI7
PTSTTETNTATSPSV	MUC16	2416	Q8WXI7
STSLVTPSTHTVITP	MUC6	1451	Q6W4X9
STTTITPNPTSTRTR	MUC6	1541	Q6W4X9
TSLVTPSTHTVITPT	MUC6	1621	Q6W4X9
ATSTSTTNITPNPTS	MUC6	1706	Q6W4X9
PSTTSVTTNTTVPDT	MGAM2	1866	Q2M2H8
TIPITTTPFATSTIS	MGAM2	1976	Q2M2H8
TPVPITTTLFATSTI	MGAM2	2016	Q2M2H8
PTSSTTVSTIATVPI	MGAM2	2086	Q2M2H8
TVSTIATVPISVTPS	MGAM2	2091	Q2M2H8
ATVPISVTPSLTSTA	MGAM2	2096	Q2M2H8
ETTTPSPTGSQTTIV	MUC22	296	E2RYF6
TYTVATPVTTSTSQP	FOXK2	451	Q01167
APTTTAPAVAVTTTT	KDM6B	741	O15054
IPPSTTTTIATSEQS	KXD1	116	Q9BQD3
TPRQSPTVTQTTGSS	MUC19	3166	Q7Z5P9
TQTPTTTPITTTTTV	MUC2	1916	Q02817
GTQTPTTTPITTTTT	MUC2	1961	Q02817
QTPTTTPITTTTTVT	MUC2	1986	Q02817
TGTQTPTTTPITTTT	MUC2	2006	Q02817
TQTPTTTPITTTTTV	MUC2	2031	Q02817
GTQTPTTTPITTTTT	MUC2	2076	Q02817
QTPTTTPITTTTTVT	MUC2	2101	Q02817
TGTQTPTTTPITTTT	MUC2	2121	Q02817
TQTPTTTPITTTTTV	MUC2	2146	Q02817
GTQTPTTTPITTTTT	MUC2	2191	Q02817
QTPTTTPITTTTTVT	MUC2	2216	Q02817
TGTQTPTTTPITTTT	MUC2	2236	Q02817
TQTPTTTPITTTTTV	MUC2	2261	Q02817
GTQTPTTTPITTTTT	MUC2	2306	Q02817
QTPTTTPITTTTTVT	MUC2	2331	Q02817
TGTQTPTTTPITTTT	MUC2	2351	Q02817
TQTPTTTPITTTTTV	MUC2	2376	Q02817
GTQTPTTTPITTTTT	MUC2	2421	Q02817
QTPTTTPITTTTTVT	MUC2	2446	Q02817
TGTQTPTTTPITTTT	MUC2	2466	Q02817
TQTPTTTPITTTTTV	MUC2	2491	Q02817
GTQTPTTTPITTTTT	MUC2	2536	Q02817
QTPTTTPITTTTTVT	MUC2	2561	Q02817
TGTQTPTTTPITTTT	MUC2	2581	Q02817
TQTPTTTPITTTTTV	MUC2	2606	Q02817
GTQTPTTTPITTTTT	MUC2	2651	Q02817
QTPTTTPITTTTTVT	MUC2	2676	Q02817
TGTQTPTTTPITTTT	MUC2	2696	Q02817
TQTPTTTPITTTTTV	MUC2	2721	Q02817
GTQTPTTTPITTTTT	MUC2	2766	Q02817
QTPTTTPITTTTTVT	MUC2	2791	Q02817
TGTQTPTTTPITTTT	MUC2	2811	Q02817
TQTPTTTPITTTTTV	MUC2	2836	Q02817
GTQTPTTTPITTTTT	MUC2	2881	Q02817
QTPTTTPITTTTTVT	MUC2	2906	Q02817
TGTQTPTTTPITTTT	MUC2	2926	Q02817
TQTPTTTPITTTTTV	MUC2	2951	Q02817
GTQTPTTTPITTTTT	MUC2	2996	Q02817
QTPTTTPITTTTTVT	MUC2	3021	Q02817
TGTQTPTTTPITTTT	MUC2	3041	Q02817
TQTPTTTPITTTTTV	MUC2	3066	Q02817
GTQTPTTTPITTTTT	MUC2	3111	Q02817
QTPTTTPITTTTTVT	MUC2	3136	Q02817
TGTQTPTTTPITTTT	MUC2	3156	Q02817
TQTPTTTPITTTTTV	MUC2	3181	Q02817
GTQTPTTTPITTTTT	MUC2	3226	Q02817
QTPTTTPITTTTTVT	MUC2	3251	Q02817
TGTQTPTTTPITTTT	MUC2	3271	Q02817
TQTPTTTPITTTTTV	MUC2	3296	Q02817
GTQTPTTTPITTTTT	MUC2	3341	Q02817
QTPTTTPITTTTTVT	MUC2	3366	Q02817
TGTQTPTTTPITTTT	MUC2	3386	Q02817
TQTPTTTPITTTTTV	MUC2	3411	Q02817
GTQTPTTTPITTTTT	MUC2	3456	Q02817
QTPTTTPITTTTTVT	MUC2	3481	Q02817
TGTQTPTTTPITTTT	MUC2	3501	Q02817
TQTPTTTPITTTTTV	MUC2	3526	Q02817
GTQTPTTTPITTTTT	MUC2	3571	Q02817
QTPTTTPITTTTTVT	MUC2	3596	Q02817
TGTQTPTTTPITTTT	MUC2	3616	Q02817
TQTPTTTPITTTTTV	MUC2	3641	Q02817
GTQTPTTTPITTTTT	MUC2	3686	Q02817
QTPTTTPITTTTTVT	MUC2	3711	Q02817
TGTQTPTTTPITTTT	MUC2	3731	Q02817
TQTPTTTPITTTTTV	MUC2	3756	Q02817
GTQTPTTTPITTTTT	MUC2	3801	Q02817
QTPTTTPITTTTTVT	MUC2	3826	Q02817
TGTQTPTTTPITTTT	MUC2	3846	Q02817
TQTPTTTPITTTTTV	MUC2	3871	Q02817
GTQTPTTTPITTTTT	MUC2	3916	Q02817
QTPTTTPITTTTTVT	MUC2	3941	Q02817
TGTQTPTTTPITTTT	MUC2	3961	Q02817
TQTPTTTPITTTTTV	MUC2	3986	Q02817
GTQTPTTTPITTTTT	MUC2	4031	Q02817
QTPTTTPITTTTTVT	MUC2	4056	Q02817
TGTQTPTTTPITTTT	MUC2	4076	Q02817
TQTPTTTPITTTTTV	MUC2	4101	Q02817
GTQTPTTTPITTTTT	MUC2	4146	Q02817
QTPTTTPITTTTTVT	MUC2	4171	Q02817
SSAPTPSTVQTTTTS	MUC2	4291	Q02817
STTTARETPIVTVTP	MUC3A	191	Q02505
TTPLSTLVTTLPTTI	MUC3A	311	Q02505
SPPITSSVTSTNTVT	MUC3A	631	Q02505
TNTVTSMTTTTSPPT	MUC3A	641	Q02505
SSTVSTGIPTSQPTT	MUC3A	811	Q02505
TVSTGIPTSQPTTIT	MUC3A	1566	Q02505
PPITSSITSTYTVTS	MUC3A	1761	Q02505
SVSSSTPVPSTEAIT	MUC3A	1796	Q02505
STPSYITSITTTETP	MUC3A	2201	Q02505
TTRTSETPVATTQTP	MUC3A	2916	Q02505
ETPVATTQTPTTLTS	MUC3A	2921	Q02505
ISQISTTLPPTTSTK	KCT2	81	Q8NC54
TSTTGVATTQSPTPR	LMO7	1576	Q8WWI1
VTTVTSQPPTTLIST	MANSC1	271	Q9H8J5
LTTSVPTPVINSTFT	MEGF9	471	Q9H1U4
TSPTLPTVTSVLTSV	LHX2	371	P50458
RTTTLVTTSTTSTPQ	MUC5AC	2251	P98088
VPTTSTISAPTTSIT	MUC5AC	2311	P98088
STISVPTTSTTSVPG	MUC5AC	2931	P98088
VPTTSTISVPTTSTT	MUC5AC	2951	P98088
TISAPTTSTTSTPQT	MUC5AC	3791	P98088
PTILVTSVTSETPAT	HGFAC	56	Q04756
TPTTATTTVSISPTT	HUWE1	3536	Q7Z6Z7
TSTTTTQQVATPGTT	NFAT5	966	O94916
TTVTTFSQSLPTAVP	POM121C	871	A8CG34
PTVAPTTIATTTTVA	NFASC	1071	O94856
VRTTTRTTTTTTPTP	FNDC1	1491	Q4ZHG4
NVTSSPTSNPVTTTK	COL6A3	2861	P12111
TSTSPTTATSPKVVI	ELF2	421	Q15723
ISTSSTPVIPNSIVS	MBD5	816	Q9P267
STTPAATNIPVITST	MUC17	296	Q685J3
TQVTTSTEASSSPPT	MUC17	481	Q685J3
LSTTPVDTSTPVTTS	MUC17	531	Q685J3
TTPVDSNTPVTTSTE	MUC17	651	Q685J3
STLSTTPVDTSTPVT	MUC17	706	Q685J3
STTPVDTSTPVTNST	MUC17	886	Q685J3
LSTTPVDTSIPVTTS	MUC17	1121	Q685J3
TSIPVSTTLVTSPEA	MUC17	1281	Q685J3
IPVSTTPVVSSEAST	MUC17	1401	Q685J3
STTPVDSNSPVVTST	MUC17	1476	Q685J3
TTPAVTSTPVTTYSQ	MUC17	1536	Q685J3
STTPVDNSTPVTTST	MUC17	1711	Q685J3
TLSTTPAVTSTPVTT	MUC17	1886	Q685J3
LSTTPVDTSTPVTNS	MUC17	2181	Q685J3
SATPVDTSTPVTTST	MUC17	2241	Q685J3
STTPVDSNSPVVTST	MUC17	2536	Q685J3
TTPVDTSIPVTTSTE	MUC17	2596	Q685J3
TLSTTPVDTSTPVTT	MUC17	2711	Q685J3
STTPVDTSTPVTTST	MUC17	2831	Q685J3
TTPVDTSIPVTTSTE	MUC17	2891	Q685J3
STLSTTPVDTRTPVT	MUC17	2946	Q685J3
PVSTTPVTSSAISTL	MUC17	3111	Q685J3
PVTSSAISTLSTTPV	MUC17	3116	Q685J3
STTPVDTSTPVTTST	MUC17	3126	Q685J3
STTPVDTSTPVTTST	MUC17	3361	Q685J3
STLSTTPVDTSTPVT	MUC17	3476	Q685J3
TSSPTNSSPTTAEVT	MUC17	3491	Q685J3
STLPVDTSTPVITST	MUC17	3656	Q685J3
VITSTQVSSSPVTPE	MUC17	3666	Q685J3
GSTLSTPSVVTSTPV	MUC17	3711	Q685J3
TPSVVTSTPVTTSTE	MUC17	3716	Q685J3
GTTIFIPSTPVTSST	MUC17	3936	Q685J3
TSTSVTTRPVTPSSE	MUC17	4036	Q685J3
RTTSFPTVTTTAVPT	MUC17	4101	Q685J3
PTVTTTAVPTNTTIK	MUC17	4106	Q685J3
STTTARETPIVTVTP	MUC3B	191	Q9H195
RETPIVTVTPSSSVS	MUC3B	196	Q9H195
NTEVITSHTTTTTPP	MUC3B	301	Q9H195
ATGTQTSPVPTTVTF	MUC3B	501	Q9H195
TQTPTTLTTCRTTPI	MUC3B	841	Q9H195
QSSPAPSTRTVTSVI	SYTL5	261	Q8TDW5
TTVVTTVPKPSSVQS	TAF4B	186	Q92750
TSSLAPVVGTTTTTP	PRCC	226	Q92733
SQQTKSTPSTSTTPT	POGZ	246	Q7Z3K3
TSTTVPTTTTVPMTT	HAVCR1	146	Q96D42
TTTSVPTTTSIPTTT	HAVCR1	186	Q96D42
IPTTTSVPVTTTVST	HAVCR1	196	Q96D42
PSTTAISSNISSPVT	SLAIN1	411	Q8ND83
ITTADTTITTNPPTT	OPRPN	146	Q99935
TTITTNPPTTATATT	OPRPN	151	Q99935
SVTQSTKLPPTTIST	IMPG2	811	Q9BZV3
SSTPVITTVSLPTSL	SSC5D	1331	A1L4H1
TTTQVTSTTTQDTTP	PRG4	956	Q92954
PPSATTTTTIGISAT	ANKHD1	1506	Q8IWZ3
PITTTTTSTTPATNT	CNOT1	1331	A5YKK6
QTSTAATTPVTLTTP	VEZF1	386	Q14119
ATTPVTLTTPFSITS	VEZF1	391	Q14119
EATTTTTTTLPQAPT	YBX3	6	P16989
VCPSPTTIVTSGTST	WDFY4	2941	Q6ZS81
ATTTTATVPTTRPVV	VASN	351	Q6EMK4
ITIPAVVSISTTSPS	WNK1	1416	Q9H4A3
VVSISTTSPSLQVPT	WNK1	1421	Q9H4A3
TTSPSLQVPTSTSEI	WNK1	1426	Q9H4A3
TTSPTTTRQMTTTPA	TIMD4	151	Q96H15